That reads like a thinly veiled press release. I would like to know if it actually, you know, works. It seems to have no customers, which should cause raised eyebrows to the agiliests among us.
If the closest comparison is to mass spec then it feels like the choice was on technique - identification of certain fragments - rather than on outcome. If so, then that's a bit like saying a camel is a better way to get across the desert than a horse, omitting that cars and airplanes are likely better still.
Also, regarding competitive methods, I could have sworn I heard exactly the same optimism regarding gene expression arrays. Like http://www.nature.com/scitable/topicpage/genetic-diagnosis-d... .
If the closest comparison is to mass spec then it feels like the choice was on technique - identification of certain fragments - rather than on outcome. If so, then that's a bit like saying a camel is a better way to get across the desert than a horse, omitting that cars and airplanes are likely better still.